Phase II trial of gemcitabine and docetaxel in patients with advanced carcinoma of the urothelium: A trial of the eastern cooperative oncology group

Gemcitabine and docetaxel are active agents in advanced urothelial carcinoma. A Phase II trial of this combination was performed to determine the activity and toxicity of these agents in a multiinstitutional setting in patients previously treated with one prior chemotherapy regimen. Twenty-nine elig...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer 2003-06, Vol.97 (11), p.2743-2747
Hauptverfasser:	DREICER, Robert, MANOLA, Judith, SCHNEIDER, Daniel J, SCHWERKOSKE, John F, GEORGE, Christopher S, ROTH, Bruce J, WILDING, George
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antimetabolites, Antineoplastic - administration & dosage Antimetabolites, Antineoplastic - adverse effects Antineoplastic agents Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Transitional Cell - drug therapy Chemotherapy Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Drug Administration Schedule Female Humans Male Medical sciences Middle Aged Paclitaxel - administration & dosage Paclitaxel - adverse effects Paclitaxel - analogs & derivatives Pharmacology. Drug treatments Taxoids Urologic Neoplasms - drug therapy Urothelium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!